The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Abel & Imray competitive analysis

Loading summary...

Explore patent oppositions filed by Abel & Imray against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3359572	Method For Treating Multiple Sclerosis	F HOFFMANN LA ROCHE	Aug 27, 2025
EP4241849	Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor Pertuzumab	F HOFFMANN LA ROCHE	Jun 18, 2025
EP4013385	Improved Lipid Nanoparticles For Delivery Of Nucleic Acids	ACUITAS THERAPEUTICS	Apr 3, 2025
EP3589661	Adjuvant Treatment Of Her2-Positive Breast Cancer	F HOFFMANN LA ROCHE	Jul 31, 2024
EP3425062	Combinatorial Sequence Barcodes For High Throughput Screening	KEYGENE	Apr 30, 2024
EP3401335	Composition Comprising Antibody That Binds To Domain Ii Of Her2 And Acidic Variants Thereof	GENENTECH	Mar 30, 2022
EP3614854	Self-Optimizing, Adaptive Industrial Chocolate Production System, And Corresponding Method Thereof	BHLER	Mar 2, 2022
EP3200602	Process For Producing A Pufa-Containing Biomass Which Has High Cell Stability	EVONIK DEGUSSA	Dec 9, 2021
EP3200605	Method For Producing Biomass Which Has A High Exopolysaccharide Content	EVONIK DEGUSSA	Dec 9, 2021

Discover the latest PTAB cases involving Abel & Imray, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Abel & Imray with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
ABEL & IMRAY	9	-	-	-
EVONIK DEGUSSA	1	47	-	-
EVONIK OPERATIONS	120	56	-	1
F HOFFMANN LA ROCHE	16	140	-	-